(Reuters Health) - When people take daily pills to minimize their chances of getting HIV, they are also more likely to get routine care like flu shots and recommended screenings for common health problems, a U.S. study suggests.
(Reuters Health) - After sex, men can sometimes experience a myriad of confusing negative feelings, a phenomenon called post-coital dysphoria (PCD), which can interfere with relationships, researchers say.
New York state on Tuesday said it has sued Purdue Pharma LP, accusing the OxyContin maker of widespread fraud and deception in the marketing of opioid products, contributing to a nationwide epidemic that has killed thousands.
(Reuters Health) - Adults who sleep too little or too much may have an increased risk of heart attack or stroke, say researchers who argue that the best way to think of the harmful effect is in terms of "excess heart age."
Democratic Republic of Congo has started using the experimental mAb114 Ebola treatment on patients in the east of the country, the health ministry said on Tuesday, the first time it has been deployed against an active outbreak.
(Reuters Health) - For decades, doctors have told parents to talk to kids as often as possible to help build speech and language skills. Now, a new study suggests that how parents talk to children may matter just as much as how much time they spend talking.
Many U.S. doctors don't discuss the harms of lung cancer screening or the potential for overdiagnosis in conversations with current and former smokers about whether tests are necessary, two new studies suggest.
(Reuters Health) - State laws designed to increase teen vaccination against the cancer-causing human papillomavirus (HPV) don't appear to influence adolescents' choices about whether to become sexually active or use condoms, a U.S. study suggests.
(Reuters Health) - When it comes to childhood obesity, sedentary behavior may be the most influential and controllable factor that parents can change, especially through managing screen time, according to a new American Heart Association Science Advisory.
Amicus Therapeutics on Monday set an average price of $315,000 per year for its newly approved Fabry disease treatment, a price it believes is below that of the main existing treatment in the United States.
A Californian court finding that a Monsanto weedkiller caused cancer in a school groundskeeper sent shares in an Australian maker of a similar product, Nufarm Ltd, tumbling almost 17 percent to a more than two-year low on Monday.
A unit of India’s Hetero Drugs is recalling some batches of the blood pressure and heart medicine valsartan in the United States, a notice on the U.S. regulator's website said, amid a wider probe into cancer risks associated with the drug.
A California jury on Friday found Monsanto liable in a lawsuit filed by a man who alleged the company's glyphosate-based weed-killers, including Roundup, caused his cancer and ordered the company to pay $289 million in damages.
U.S. health regulators on Friday approved Amicus Therapeutics' Galafold, the first oral therapy to treat Fabry disease, a rare, sometimes fatal condition in which accumulation of fat damages several organs.